LS007, a potent and orally bioavailable CDK9 inhibitor, suppresses the growth of triple-negative and estrogen receptor-positive breast cancer

被引：0
|
作者：
Rahaman, Muhammed Hamidur [1 ]
Zhang, Yinghui [1 ]
Islam, Md Saiful [1 ]
Heinemann, Gary [1 ]
Anshabo, Abel Tesfaye [1 ]
Albrecht, Hugo [1 ]
Milne, Robert [1 ]
Wang, Shudong [1 ]
机构：
[1] Univ South Australia, Adelaide, SA, Australia
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4427
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
    Wang, Wen-Jing
    Gao, Lixin
    Wang, Simei
    Huang, Wensi
    Meng, Xin-Yu
    Hu, Hao
    Chen, Ziqiang
    Sun, Jingya
    Yuan, Yali
    Zhou, Yubo
    Diao, Xingxing
    Huang, Ruimin
    Li, Jia
    Chen, Xiao-Hua
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (12) : 10035 - 10056
  • [2] Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer
    Nie, Hui-Jun
    Li, Ben-Fu
    Sun, Jingya
    Yuan, Yali
    Zhang, Zhi-Gao
    Hu, Hao
    Wang, Wen-Jing
    Chen, Ziqiang
    Wang, Simei
    Huang, Wensi
    Diao, Xingxing
    Yu, Jinghua
    Huang, Ruimin
    Chen, Xiao-Hua
    BIOORGANIC CHEMISTRY, 2024, 153
  • [3] Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
    Lee, Sang Min
    Kang, Eun Jin
    Kim, Ju Hee
    Yun, Jong Min
    Sun, Der Sheng
    Ko, Yoon Ho
    Won, Hye Sung
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (03): : 411 - 414
  • [4] Differential metabolic response of triple-negative and estrogen receptor-positive breast cancer cells to abemaciclib, a CDK4/6 inhibitor
    Jiang, Jun
    Bao, Xun
    Jiang, Yuanyuan
    Yue, Yang
    Huettemann, Maik
    Li, Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Androgen receptor-positive, triple-negative breast cancer
    Gucalp, Ayca
    Traina, Tiffany A.
    CANCER, 2017, 123 (10) : 1686 - 1688
  • [6] Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer
    Wei, Dan
    Wang, Hanlin
    Zeng, Qinghe
    Wang, Wenjing
    Hao, Bingbing
    Feng, Xule
    Wang, Peipei
    Song, Ning
    Kan, Weijuan
    Huang, Guifang
    Zhou, Xiaoyu
    Tan, Minjia
    Zhou, Yubo
    Huang, Ruimin
    Li, Jia
    Chen, Xiao-Hua
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14822 - 14847
  • [7] Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
    Aristomenis Anestis
    Panagiotis Sarantis
    Stamatios Theocharis
    Ilianna Zoi
    Dimitrios Tryfonopoulos
    Athanasios Korogiannos
    Anna Koumarianou
    Evangelia Xingi
    Dimitra Thomaidou
    Michalis Kontos
    Athanasios G. Papavassiliou
    Michalis V. Karamouzis
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 1221 - 1233
  • [8] Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
    Anestis, Aristomenis
    Sarantis, Panagiotis
    Theocharis, Stamatios
    Zoi, Ilianna
    Tryfonopoulos, Dimitrios
    Korogiannos, Athanasios
    Koumarianou, Anna
    Xingi, Evangelia
    Thomaidou, Dimitra
    Kontos, Michalis
    Papavassiliou, Athanasios G.
    Karamouzis, Michalis V.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (05) : 1221 - 1233
  • [9] Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer
    Phipps, Amanda I.
    Chlebowski, Rowan T.
    Prentice, Ross
    McTiernan, Anne
    Stefanick, Marcia L.
    Wactawski-Wende, Jean
    Kuller, Lewis H.
    Adams-Campbell, Lucile L.
    Lane, Dorothy
    Vitolins, Mara
    Kabat, Geoffrey C.
    Rohan, Thomas E.
    Li, Christopher I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (03) : 454 - 463
  • [10] Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison
    Spoelstra, Nicole S.
    Cittelly, Diana M.
    Christenson, Jessica L.
    Gordon, Michael A.
    Elias, Anthony
    Jedlicka, Paul
    Richer, Jennifer K.
    HUMAN PATHOLOGY, 2016, 56 : 40 - 51
12345